X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/22/2851134/0/en/Salarius-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/22/2833642/0/en/Salarius-Provides-Update-on-Strategic-Review-Process-and-Plans-to-Support-Ongoing-Seclidemstat-Clinical-Trials-by-Further-Reducing-Expenses.html
https://www.globenewswire.com//news-release/2024/01/16/2809838/0/en/Salarius-Pharmaceuticals-Issued-U-S-Patent-for-Next-Generation-Targeted-Protein-Degraders.html
https://www.globenewswire.com//news-release/2024/01/03/2803302/0/en/Investigator-initiated-Phase-1-2-Clinical-Trial-Using-Salarius-Pharmaceuticals-Seclidemstat-in-Combination-with-Azacitidine-to-Treat-Hematologic-Cancers-Resumes-Patient-Enrollment.html
https://www.globenewswire.com//news-release/2023/11/07/2775117/0/en/Salarius-Completes-FDA-Type-B-Meeting-for-Seclidemstat-Ewing-Sarcoma-Development-Program.html
https://www.fiercebiotech.com/biotech/cash-strapped-salarius-lays-over-50-staff-clinical-ambitions-prove-too-costly
https://www.globenewswire.com/news-release/2023/08/10/2723137/0/en/Salarius-Pharmaceuticals-Reports-Second-Quarter-2023-Financial-Results-and-Provides-a-Business-Update.html
https://www.globenewswire.com/news-release/2023/08/08/2721166/0/en/Salarius-Pharmaceuticals-Announces-Plans-to-Explore-Strategic-Alternatives-and-Implement-Measures-to-Extend-its-Resources.html
https://www.globenewswire.com/news-release/2023/07/11/2702641/0/en/Salarius-Pharmaceuticals-Receives-FDA-Clearance-of-SP-3164-Investigational-New-Drug-Application-to-Begin-a-Phase-1-Clinical-Trial-in-Relapsed-Refractory-Non-Hodgkin-Lymphoma-Patien.html
https://www.globenewswire.com/news-release/2023/06/12/2686231/0/en/Salarius-Pharmaceuticals-Presents-SP-3164-Targeted-Protein-Degrader-Preclinical-Data-at-the-European-Hematology-Association-2023-Hybrid-Congress.html
Market Place
Share 
